XOMA Royalty (XOMA) Operating Leases (2019 - 2026)
XOMA Royalty's (XOMA) quarterly Operating Leases came in at $19.5 million in Q1 2026, up 4775.0% year-on-year from $400000.0 in Q1 2025, and down 3.05% quarter-over-quarter from $20.1 million in Q4 2025.
XOMA Royalty (XOMA) Operating Leases (2019 - 2026) Analysis & Trends
XOMA Royalty has disclosed Operating Leases across 7 years of filings, most recently posting $19.5 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $19.5 million, up 4775.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.5 million (up 4775.0% YoY), and the FY2025 annual result was $20.1 million, up 3922.8% from the prior year.
- Operating Leases came in at $19.5 million for Q1 2026 at XOMA Royalty, down from $20.1 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $20.7 million in Q3 2025 to a low of $238000.0 in Q2 2025.
- The 4-year median for Operating Leases is $547000.0 (2024), against an average of $6.3 million.
- Across the five-year window, Operating Leases slumped 66.48% in 2025 and jumped 4775.0% in 2026, its largest moves.
- XOMA Royalty's Operating Leases stood at $300000.0 in 2023, then jumped by 66.67% to $500000.0 in 2024, then jumped by 3922.8% to $20.1 million in 2025, then slipped by 3.05% to $19.5 million in 2026.
- The last three Operating Leases figures came in at $19.5 million (Q1 2026), $20.1 million (Q4 2025), and $20.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.50 Mn |
| Dec 31, 2025 | 20.11 Mn |
| Sep 30, 2025 | 20.70 Mn |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 594,000.00 |
| Jun 30, 2024 | 710,000.00 |
| Mar 31, 2024 | 319,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 85,000.00 |
| Jun 30, 2021 | 133,000.00 |
| Mar 31, 2021 | 182,000.00 |
| Dec 31, 2020 | 229,000.00 |
| Sep 30, 2020 | 275,000.00 |
| Jun 30, 2020 | 320,000.00 |
| Mar 31, 2020 | 365,000.00 |
| Dec 31, 2019 | 408,000.00 |
| Sep 30, 2019 | 5.19 Mn |